However, because tirzepatide already severely limits appetite, adding fasting on top can push calorie intake dangerously low
Primary concerns include additive cardiovascular effects (tachycardia, hypertension), intensified gastrointestinal symptoms (nausea, vomiting, constipation), central nervous system effects (insomnia, anxiety), and excessive appetite suppression potentially leading to nutritional deficiencies
named here only to identify the research pathway Ipamorelin acts on
Realistic Expectations for GLP-1 Weight Loss Medications As interest in weight loss medications increases, it is important to maintain realistic expectations
This phase of growth will be shaped by rapid expansion in treatment access through private insurance and self-pay channels, increasing clinical adoption for cardiovascular risk reduction, and growing physician confidence in long-term safety profiles